A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
This study is investigating a new medicine, Dapiglutide, designed to help with weight management. We're especially interested in how your body processes two different strengths of this medication when it's given as an injection just under the skin. This includes understanding how much medicine gets into your system, how long it stays there, and how your body breaks it down. We'll also be carefully checking for any side effects to see if the medicine is safe and well-tolerated. This is an early-stage study, meaning it's one of the first times this medicine is being tested in people. Our aim is to gather important information that will help us decide if this medicine should be tested further.
At a glance
What is this study about?
This study is about a new medicine called Dapiglutide, which is being explored as a possible treatment to help people manage their weight. We're trying to learn more about how this medicine works in the body. Specifically, we'll be looking at two different strengths of Dapiglutide, given as an injection just under the skin, similar to a regular shot you might get.
The main goal is to understand how your body handles the medicine. This involves seeing how much of the medicine gets absorbed, how it travels through your body, and how long it takes for your body to get rid of it. This information is really important because it helps doctors and researchers figure out the best dose and how often the medicine should be given to work effectively and safely.
Another very important part of this study is to check for safety. We want to know if the medicine causes any side effects and how well people tolerate it. This is a "Phase I" study, which means it's an early step in testing a new medicine in humans. The information we gather will help us decide if Dapiglutide is a promising treatment and if it should be studied in more detail with more people in the future.
Key takeaways
- This study is testing a new weight management medicine called Dapiglutide.
- It's an early-stage study looking at how the body handles different strengths of the medicine.
- The medicine is given as an injection under the skin.
- Researchers will check for safety and any side effects.
- Adults aged 18 and older, both men and women, can potentially take part.
- Your medical care won't be affected if you choose to leave the study early.
Who may be eligible?
To be considered for this study, you need to be an adult, aged 18 years or older. There is no upper age limit, meaning older adults can also take part.
This study is open to both men and women, as we want to understand how the medicine works across different people.
Beyond these basic requirements, the research team will check for other health information to make sure the study is a good fit for you and safe for you to participate in. This typically involves reviewing your medical history and sometimes a physical exam. They will explain everything clearly before you make any decisions.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you able to attend clinic visits regularly?
- Are you comfortable with receiving injections?
- Do you understand that this is an early-stage study for a new medicine?
- Are you willing to share your medical history with the study team?
What does participation involve?
If you decide to take part in this study, you would receive injections of the study medicine, Dapiglutide, under your skin. Since we are testing two different strengths, you might receive one of these strengths, though you wouldn't know which one you are getting at the time. You would also have regular visits to the clinic so the research team can monitor your health, check for any side effects, and take blood samples to understand how the medication is working in your body.
These visits will involve various assessments, such as physical exams, blood pressure checks, and possibly heart readings. The full duration of your participation, including how many visits and how long you would be followed up for, would be explained in detail by the study team. You would be given all the information about the schedule and what is expected of you before you agree to join.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is Dapiglutide?
Dapiglutide is a new medicine being studied to help people manage their weight.
How is the medicine given?
It is given as an injection just under the skin, similar to other common injections.
Is this a new medicine?
Yes, this is an early-stage study, meaning it's one of the first times this medicine is being tested in people.
Will I know if I'm getting the medicine?
Yes, everyone in this study will receive the study medicine, but you might not know which strength you are getting.
Can I leave the study at any time?
Yes, you are free to leave the study at any point without it affecting your future medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.